查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1358160

奈米抗体市场：按产品类型、按治疗领域、按用途、按最终用户、按地区

Nanobodies Market, By Product Type, By Therapeutic Area, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2023 年，全球奈米抗体市场价值将达到 3.686 亿美元，预测期内（2023-2030 年）年复合成长率为 24.1%。

报告范围 报告详情
基准年 2022年 2023年市场规模 3.686 亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 24.10% 2030年市场规模预测 16.719 亿美元
奈米抗体全球市场占有率(%)（依产品类型），2023 年
奈米抗体市场-IMG1

单域抗体，又称“奈米抗体”，衍生哺乳动物重链抗体，其特征是奈米级尺寸、刚性结构、在水溶液中稳定可溶性的行为、可逆的蛋白质折迭、以及高亲和性等特殊特性。以及仅针对一个同源目标的特异性。奈米抗体具有从基础科学到临床治疗的多种应用。奈米抗体的小尺寸和单域链提供了大的结合表面和低的特异性背景结合，使它们可用作亲和捕获试剂。此外，奈米抗体已被证明可以透过抑製血栓症交互作用来有效治疗癌症，例如拮抗血管性血友病因子以预防血栓形成和抑制抗TNF-horse以治疗关节炎，也可用于治疗其他疾病。奈米抗体还可以在细胞内表达并与萤光蛋白融合以监测抗原活性。奈米抗体适合作为蛋白质稳定剂，这在蛋白质结晶中尤其重要。因此，奈米抗体因其能够将蛋白质固定在特定构象并稳定柔性结构域而被用于许多蛋白质结晶研究。因此，奈米抗体的采用不断增加，推动了奈米抗体市场的成长。

市场动态

奈米抗体市场的主要参与者正在投资研发，并专注于开发新产品以加强产品系列。因此，将此类先进产品引入市场预计将在预测期内推动全球奈米抗体市场的成长。例如，2020年10月，全球科技公司默克公司与全球医疗保健公司诺华公司合作开发了M6495，这是一种具有治疗骨关节炎（OA）潜力的抗ADAMTS5奈米抗体。关于开发的许可协议这增加了骨关节炎患者的治疗选择。

本研究的主要特点

  • 本报告详细分析了全球奈米抗体市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率(CAGR) 。
  • 它还揭示了各个细分市场的潜在收入机会，并为市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球奈米抗体市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、经营团队升级、市场扩张和行销策略做出明智的资讯。
  • 全球奈米抗体市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球奈米抗体市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第3章市场动态、法规及趋势分析

  • 市场动态
  • 促进因素
  • 抑制因素
  • 机会
    • 最近的趋势
    • 合併、收购和合作
    • 法规场景
    • 主要进展
    • PEST分析
    • 波特的分析

第4章全球奈米抗体市场，COVID-19 的影响分析

    • 经济影响
    • 新型冠状病毒（COVID-19）的流行病学
    • 对需求和供给的影响

第5章全球奈米抗体市场，依产品类型，2018-2030

  • 单价奈米抗体
  • 二价奈米抗体
  • 双特异性奈米抗体
  • 双互补位奈米抗体
  • 多效价奈米抗体
  • 融合奈米抗体

第6章全球奈米抗体市场，依治疗领域，2018-2030

  • 肿瘤学
  • 感染疾病
  • 发炎与自体免疫疾病
  • 神经系统疾病
  • 其他的

第7章全球奈米抗体市场，依用途，2018-2030

  • 治疗性的
  • 诊断
  • 调查

第8章全球奈米抗体市场，按最终用户划分，2018-2030 年

  • 医院
  • 生物製药公司
  • 诊断实验室
  • 其他的

第9章全球奈米抗体市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • 公司简介
    • Merck KGaA
    • Sanofi
    • AlpalifeB Inc
    • GenScript
    • Novartis International AG
    • Taisho Pharmaceutical Holdings Co., Ltd.
    • Sino Biological, Inc.
    • GeneMedi
    • Biocytogen
    • Abnova Corporation
    • NanoTag Biotechnologies
    • Avillion LLP
    • Capra Science
    • Numab Therapeutics
    • CUSABIO TECHNOLOGY LLC
    • Proteintech Group, Inc.
    • GT Biopharma, Inc.
    • Confo Therapeutics
    • R&D Systems, Inc.
    • Abcepta Biotech Ltd. Co.
  • 分析师观点

第11章章节

  • 参考
  • 调查方法
简介目录
Product Code: CMI1680

The global nanobodies market is estimated to be valued at US$ 368.6 million in 2023 and is expected to exhibit a CAGR of 24.1% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 368.6 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 24.10% 2030 Value Projection: US$ 1,671.9 Mn
Global Nanobodies Market Share (%), By Product Type, 2023
Nanobodies Market - IMG1

Single-domain antibodies known as "nanobodies" are derived from heavy-chain antibodies in mammals and have special characteristics such as nanoscale size, robust structure, stable and soluble behaviours in aqueous solution, reversible protein folding, high affinity and specificity for only one cognate target, among others. Nanobodies have a variety of applications, ranging from basic science to clinical therapeutics. Due to the small size and single-domain chain, nanobodies have a larger binding surface and lower nonspecific background binding and are used as affinity capture reagents. Furthermore, nanobodies can be used to treat cancer and other diseases by blocking ligand-receptor interactions, such as antagonizing the anti-von Willebrand factor to prevent thrombosis or inhibiting anti-TNF-α to treat arthritis. Nanobodies can also be expressed inside cells and fused with a fluorescent protein to monitor antigen activity. Nanobodies are well suited as protein stabilizers, which is particularly important during the crystallization of a protein. Thus, nanobodies are used in a number of protein crystallization studies due to the ability of nanobodies to lock proteins in a particular conformation stabilize flexible domains. This, increases the adoption of nanobodies and, thereby, drives the growth of the nanobodies market.

Market Dynamics

The key players in the nanobodies market are focusing on the development of new products by investing in research and development to strengthen their product portfolio. Thus, the introduction of such advanced products in the market is expected to drive growth of the global nanobodies market over the forecast period. For instance, in October 2020, Merck KGaA, a global science and technology company, entered into an out-licensing agreement with Novartis AG, a global healthcare company, for the development of M6495, an anti-ADAMTS5 nanobody, for the potential treatment of osteoarthritis (OA). This increased treatment option for osteoarthritis patients.

Key features of the study:

  • The report provides an in-depth analysis of the global nanobodies market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for the market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global nanobodies market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of thestudy include Merck KGaA, Sanofi, AlpalifeB Inc, GenScript, Novartis International AG, Taisho Pharmaceutical Holdings Co., Ltd., Sino Biological, Inc., GeneMedi, Biocytogen, Abnova Corporation, NanoTag Biotechnologies, Avillion LLP, Capra Science, Numab Therapeutics, CUSABIO TECHNOLOGY LLC, Proteintech Group, Inc., GT Biopharma, Inc., Confo Therapeutics, R&D Systems, Inc., Abcepta Biotech Ltd. Co.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global nanobodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nanobodies market

Detailed Segmentation:

  • Global Nanobodies Market, By Product Type:
    • Monovalent Nanobodies
    • Bivalent Nanobodies
    • Bispecific Nanobodies
    • Biparatopic Nanobodies
    • Multivalent Nanobodies
    • Fusion Nanobodies
  • Global Nanobodies Market, By Therapeutic Area:
    • Oncology
    • Infectious Diseases
    • Inflammatory and Autoimmune Diseases
    • Neurological Disorders
    • Others
  • Global Nanobodies Market, By Application:
    • Therapeutic
    • Diagnostic
    • Research
  • Global Nanobodies Market, By End User:
    • Hospitals
    • Biopharmaceutical Companies
    • Diagnostic Laboratories
    • Others
  • Global Nanobodies Market, By Region:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles
    • Merck KGaA
    • Sanofi
    • AlpalifeB Inc
    • GenScript
    • Novartis International AG
    • Taisho Pharmaceutical Holdings Co., Ltd.
    • Sino Biological, Inc.
    • GeneMedi
    • Biocytogen
    • Abnova Corporation
    • NanoTag Biotechnologies
    • Avillion LLP
    • Capra Science
    • Numab Therapeutics
    • CUSABIO TECHNOLOGY LLC
    • Proteintech Group, Inc.
    • GT Biopharma, Inc.
    • Confo Therapeutics
    • R&D Systems, Inc.
    • Abcepta Biotech Ltd. Co.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Therapeutic Area
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
    • Recent Trends
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
    • PORTER's Analysis

4. Global Nanobodies Market - COVID-19 Impact Analysis

    • Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand

5. Global Nanobodies Market, By Product Type, 2018- 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Monovalent Nanobodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Bivalent Nanobodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Bispecific Nanobodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Biparatopic Nanobodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Multivalent Nanobodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Fusion Nanobodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends

6. Global Nanobodies Market, By Therapeutic Area, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Inflammatory and Autoimmune Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends

7. Global Nanobodies Market, By Application, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Therapeutic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Diagnostic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends

8. Global Nanobodies Market, By End User, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends

9. Global Nanobodies Market, By Region, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • North America
    • Market Size and Forecast,Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast,Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast,Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast,Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Market Size and Forecast,Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast,Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profiles
    • Merck KGaA
    • Sanofi
    • AlpalifeB Inc
    • GenScript
    • Novartis International AG
    • Taisho Pharmaceutical Holdings Co., Ltd.
    • Sino Biological, Inc.
    • GeneMedi
    • Biocytogen
    • Abnova Corporation
    • NanoTag Biotechnologies
    • Avillion LLP
    • Capra Science
    • Numab Therapeutics
    • CUSABIO TECHNOLOGY LLC
    • Proteintech Group, Inc.
    • GT Biopharma, Inc.
    • Confo Therapeutics
    • R&D Systems, Inc.
    • Abcepta Biotech Ltd. Co.
  • Analysts' Views

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact